Safety profile of a novel peptide, PIN201104, with potential to act as a disease modifying, broad spectrum treatment for asthma

Conclusion: From these studies, 104 does not show potential to induce significant safety concerns going into clinical development.

Source: European Respiratory Journal - November 19, 2018 Category: Respiratory Medicine Authors: Watson, J., Federici-Canova, D., Cooper, N., Burgess, C. Tags: Allergy and immunology Source Type: research